S. Sagar

840 total citations
27 papers, 627 citations indexed

About

S. Sagar is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, S. Sagar has authored 27 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Nephrology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in S. Sagar's work include Vasculitis and related conditions (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Mosquito-borne diseases and control (4 papers). S. Sagar is often cited by papers focused on Vasculitis and related conditions (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Mosquito-borne diseases and control (4 papers). S. Sagar collaborates with scholars based in India, United States and Japan. S. Sagar's co-authors include Bal Krishan Sharma, Nirmal Kumar Ganguly, Sanjay Jain, S. Suri, Michiyoshi Yajima, Fujío Numano, Satbir S. Sehgal, N K Ganguly, K. S. Chugh and O P Kalra and has published in prestigious journals such as American Journal of Epidemiology, American Journal of Physiology-Renal Physiology and Molecular and Cellular Biochemistry.

In The Last Decade

S. Sagar

26 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Sagar India 13 325 144 100 93 92 27 627
Zuhal Parıldar Türkiye 14 72 0.2× 77 0.5× 104 1.0× 101 1.1× 29 0.3× 32 569
C B Marenah United Kingdom 17 88 0.3× 68 0.5× 76 0.8× 84 0.9× 37 0.4× 30 670
Guillermo Tate United States 12 91 0.3× 56 0.4× 22 0.2× 37 0.4× 74 0.8× 17 539
Abdülkerim Bedir Türkiye 15 62 0.2× 111 0.8× 63 0.6× 67 0.7× 31 0.3× 60 725
Shirong Cao United States 15 106 0.3× 240 1.7× 53 0.5× 52 0.6× 94 1.0× 23 690
Michiel P. C. Siroen Netherlands 12 95 0.3× 71 0.5× 165 1.6× 308 3.3× 27 0.3× 20 706
Carla Ferri Spain 14 51 0.2× 322 2.2× 68 0.7× 36 0.4× 69 0.8× 33 691
Tae‐Sun Ha South Korea 15 116 0.4× 217 1.5× 60 0.6× 28 0.3× 49 0.5× 47 592
Nobuhiko Satoh Japan 15 54 0.2× 81 0.6× 58 0.6× 82 0.9× 34 0.4× 32 577

Countries citing papers authored by S. Sagar

Since Specialization
Citations

This map shows the geographic impact of S. Sagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Sagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Sagar more than expected).

Fields of papers citing papers by S. Sagar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Sagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Sagar. The network helps show where S. Sagar may publish in the future.

Co-authorship network of co-authors of S. Sagar

This figure shows the co-authorship network connecting the top 25 collaborators of S. Sagar. A scholar is included among the top collaborators of S. Sagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Sagar. S. Sagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sagar, S., et al.. (2022). Mathematical modeling in perspective of vector-borne viral infections: a review. Beni-Suef University Journal of Basic and Applied Sciences. 11(1). 102–102. 4 indexed citations
2.
Sagar, S.. (2021). SIR-SI Mathematical Model for Zika Virus Progression Dynamics in India: A Case Study. JOURNAL OF COMMUNICABLE DISEASES. 53(2). 100–104. 3 indexed citations
3.
Sagar, S.. (2021). miR-106b as an emerging therapeutic target in cancer. Genes & Diseases. 9(4). 889–899. 29 indexed citations
4.
Sharma, Nidhi, et al.. (2019). General obesity and Cardiovascular diseases among Gaur Brahmin population of NCR/Delhi. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 13(2). 1335–1339. 1 indexed citations
5.
Kaul-Ghanekar, Ruchika, et al.. (2018). Effect of aqueous/methanolic extract of Ocimum sanctum (OciBest) on the Male and Female reproductive performance of wistar rats. Pharmacognosy Magazine. 14(55). 256–256.
6.
Sagar, S., et al.. (2009). Status, distribution and management of newly identified wild rose Rosa soulieana Crep. in Kaziranga National Park.. Indian Forester. 135(7). 954–959. 1 indexed citations
7.
Sagar, S., Satbir S. Sehgal, & Sandeep Agarwala. (1999). Bioactivity of ethanol extract of Karanja (Pongamia glabra vent) seed coat against mosquitoes.. PubMed. 31(2). 107–11. 7 indexed citations
8.
Mehra, Narinder K., Raja Rajalingam, S. Sagar, Sanjay Jain, & Bal Krishan Sharma. (1996). Direct role of HLA-B5 in influencing susceptibility to Takayasu Aortoarteritis. International Journal of Cardiology. 54. S71–S79. 14 indexed citations
9.
Sharma, Bal Krishan, Sanjay Jain, & S. Sagar. (1996). Systemic manifestations of Takayasu arteritis: The expanding spectrum. International Journal of Cardiology. 54. S149–S154. 50 indexed citations
10.
Mehra, Narinder K., Raja Rajalingam, S. Sagar, Sanjay Jain, & Bal Krishan Sharma. (1996). Direct role of HLA-B5 in influencing susceptibility to Takayasu Aortoarteritis. International Journal of Cardiology. 54. S55–S63. 3 indexed citations
11.
Sagar, S. & Satbir S. Sehgal. (1996). Effects of aqueous extract of deoiled neem (Azadirachta Indica A. juss) seed kernel and karanja (Pongamia Glabra vent) seed kernel against Culex quinquefasciatus.. PubMed. 28(4). 260–9. 19 indexed citations
12.
Sharma, Bal Krishan, Sanjay Jain, & S. Sagar. (1996). Systemic manifestations of Takayasu arteritis: The expanding spectrum. International Journal of Cardiology. 54. S121–S126. 12 indexed citations
13.
Sagar, S., Nora Gibbons, Elsa Valderrama, & Pravin C. Singhal. (1995). Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.. PubMed. 44(6). 356–61. 4 indexed citations
14.
Yajima, Michiyoshi, et al.. (1993). COMPARATIVE STUDIES OF PATIENTS WITH TAKAYASU ARTERITIS IN JAPAN, KOREA AND INDIA : Comparison of Clinical Manifestations, Angiography and HLA-B Antigen. Japanese Circulation Journal. 58(1). 9–14. 64 indexed citations
15.
Wahi, S., S. Sagar, & Sharma Bk. (1993). Is a hypertensive always a hypertensive?. PubMed. 41(4). 198–9. 1 indexed citations
16.
Sagar, S., et al.. (1992). Immunopathogenesis of Takayasu arteritis. Heart and Vessels. 7(S1). 85–90. 45 indexed citations
17.
Sagar, S., et al.. (1992). Oxygen free radicals in essential hypertension. Molecular and Cellular Biochemistry. 111(1-2). 103–8. 148 indexed citations
18.
Sharma, Bal Krishan, et al.. (1992). Takayasu arteritis in India. Heart and Vessels. 7(S1). 37–43. 80 indexed citations
19.
Sharma, B, S. Sagar, P. L. Wahi, et al.. (1991). Blood Pressure in Schoolchildren in Northwest India. American Journal of Epidemiology. 134(12). 1417–1426. 26 indexed citations
20.
Sagar, S., et al.. (1982). Plasma renin activity in essential hypertensives in north India.. PubMed. 75. 101–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026